In tumor cells, PTEN acts as an anti-proliferative agent by inhibiting cyclin D1 transcription through AKT inactivation and increasing lipid phosphatase activity in the cytoplasm, resulting in elevated p27 expression. This evidence concerns the gene CDKN1B and neoplasm.